First Manufacturer to Receive New Official Approval of the e-Health Card in Germany

On October 1 2011, Germany will begin the country-wide distribution of its new electronic health card. Morpho (Safran group) is the first manufacturer to have received official approval for production of the card. This was confirmed by gematik (Gesellschaft für Telematikanwendungen der Gesundheitskarte) - the German association for telematics applications for the e-health card. This means that Morpho can now make the approved e-health card available to health insurers for upcoming distribution. By the end of the year, 10% of all insured persons will receive the new card.

The new e-health card, called "Generation 1plus", is already suited for future online use and has high-security encryption functions.

The production facility at the German manufacturing site in Flintbek near Kiel has successfully implemented the required security measures and is ready to start production. One in three persons in Germany insured under a statutory health insurance program will receive an e-health card produced in Flintbek. That makes Morpho one of the market leaders in terms of the total volume of electronic health cards.

"We are pleased to be the first company to have received full approval for our Generation 1plus e-health card which will be ready for the launch of distribution. At the same time, we are sure the initial rollout will pave the way for a full rollout in 2012 and in subsequent years," said Christopher Goulet, Head of Sales for Central and Eastern Europe, Payment and ID Documents at Morpho, e-Documents Division.

About Morpho
Morpho, a high-technology company in the Safran group, is one of the world's leading suppliers of identification, detection and e-document solutions. Morpho is specialized in personal rights and flow management applications, in particular based on biometrics, a sector in which it is the world leader, as well as secure terminals and smart cards. Morpho's integrated systems and equipment are deployed worldwide and contribute to the safety and security of transportation, data, people and countries. Through its e-Documents Division, Morpho is a worldwide leader in identity documents and secure credentials. It delivers trust in the digital world through smart cards, passports, tokens, personalized and blank documents. The technology expertise of the e-Documents Division shapes the markets for the ID document, payment, telecoms and Identity Access Management segments. With 2,800 employees, worldwide subsidiaries and 6 production and 9 development centers, the Division is close to its customers all over the globe.

For more information: www.morpho.com

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...